Healthcare & Medical Devices Global On demand · 24-48h

Global High-Intensity Focused Ultrasound (HIFU) Therapy Device Market Strategic Research Report

Global High-Intensity Focused Ultrasound (HIFU) Therapy Devi…
$3,500 USD
Market Research Reports
Strategic Research Report
Global High-Intensity Focused Ultrasound (HIFU) Therapy Device Market
$1.4B2025
6.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Ultrasound-Guided Type, MRI-Guided Type

By Application: Oncology Treatment, Gynecological Treatment, Prostate Treatment, Aesthetic Body Contouring, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: InSightec, EDAP TMS, Profound Medical, Theraclion, Chongqing Haifu, Shanghai A&S, Alpinion, EpiSonica, Shanghai Shende Green Medical Era, Sinoways, Shenzhen PRO-HITU, Wikkon, Mianyang Sonic, Sonablate, Yuande Bio-Medical Engineering

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 116 pages
Market size 2025
$1.4B
Billion USD
Forecast CAGR
6.4%
2025-2032
Forecast 2032
$2.2B
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global High-Intensity Focused Ultrasound (HIFU) Therapy Device market size is predicted to grow from US$ 1,399 million in 2025 to US$ 2,114 million in 2032; it is expected to grow at a CAGR of 6.4% from 2026 to 2032.

A high-intensity focused ultrasound (HIFU) therapy device is a non-invasive or minimally invasive therapeutic system that uses high-energy ultrasound waves to generate localized thermal or mechanical effects at a targeted focal point within the body. By concentrating acoustic energy into a small focal region, the system induces rapid temperature elevation (typically above 60–100°C) or cavitation effects, resulting in precise coagulative necrosis while minimizing damage to surrounding tissues.

The system typically consists of an ultrasonic energy generator and control module, a focused transducer assembly, a real-time imaging guidance system (ultrasound-guided or MRI-guided), a patient positioning and treatment table system, and cooling and safety monitoring modules. Key technologies include precision beam focusing algorithms, graded energy delivery control, temperature or echo-feedback closed-loop systems, and three-dimensional targeting and treatment planning software.

Upstream suppliers include piezoelectric ceramic materials, precision acoustic transducer components, medical imaging modules, and embedded control software developers. Downstream customers include oncology departments, gynecology units, urology centers, and aesthetic medicine clinics. The overall industry gross margin generally ranges from 50% to 70%, reflecting high technological barriers and strong regulatory requirements in advanced therapeutic equipment markets.

In 2025, the global production of high-intensity focused ultrasound (HIFU) therapy device was 2,600 units, with an average price of US$550,000 per unit.

Global key High-Intensity Focused Ultrasound (HIFU) Therapy Device players cover InSightec, EDAP TMS, Profound Medical, Theraclion, Chongqing Haifu, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global High-Intensity Focused Ultrasound (HIFU) Therapy Device market?

What factors are driving High-Intensity Focused Ultrasound (HIFU) Therapy Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do High-Intensity Focused Ultrasound (HIFU) Therapy Device market opportunities vary by end market size?

How does High-Intensity Focused Ultrasound (HIFU) Therapy Device break out by Type, by Application?

This report presents a comprehensive overview of the global High-Intensity Focused Ultrasound (HIFU) Therapy Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Ultrasound-Guided Type
  • MRI-Guided Type

Segment by Structure

  • Extracorporeal Focusing Type
  • Intracavitary Treatment Type

Segment by Technology

  • Single-Focus Scanning Type
  • Multi-Focus Array Type

Segment by Application

  • Oncology Treatment
  • Gynecological Treatment
  • Prostate Treatment
  • Aesthetic Body Contouring
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global High-Intensity Focused Ultrasound (HIFU) Therapy Device market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Oncology Treatment, Gynecological Treatment, Prostate Treatment evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global High-Intensity Focused Ultrasound (HIFU) Therapy Device Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$1.4B
2025
Forecast
$2.2B
2032
CAGR
6.4%
2025–2032
Regiones
5
global
Key companies
InSightecEDAP TMSProfound MedicalTheraclionChongqing HaifuShanghai A&SAlpinionEpiSonica
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Ultrasound-Guided TypeMRI-Guided Type
By Application
Oncology TreatmentGynecological TreatmentProstate TreatmentAesthetic Body ContouringOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Ultrasound-Guided Type
  • 3.1.3 MRI-Guided Type
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Oncology Treatment
  • 4.1.3 Gynecological Treatment
  • 4.1.4 Prostate Treatment
  • 4.1.5 Aesthetic Body Contouring
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 InSightec
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 EDAP TMS
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Profound Medical
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Theraclion
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Chongqing Haifu
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Shanghai A&S
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Alpinion
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 EpiSonica
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Shanghai Shende Green Medical Era
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Sinoways
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Shenzhen PRO-HITU
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Wikkon
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Mianyang Sonic
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Sonablate
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Yuande Bio-Medical Engineering
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global High-Intensity Focused Ultrasound (HIFU) Therapy Device market size?
The global High-Intensity Focused Ultrasound (HIFU) Therapy Device market is estimated at US$ 1.4 billion in 2025 (base year) and is projected to reach US$ 2.11 billion by 2032.
What growth rate is expected for the High-Intensity Focused Ultrasound (HIFU) Therapy Device market through 2032?
The market is expected to grow at a CAGR of 6.4% from 2026 to 2032, expanding from US$ 1.4 billion in 2025 to US$ 2.11 billion in 2032, roughly 1.5 times its base-year value.
How is High-Intensity Focused Ultrasound (HIFU) Therapy Device defined?
A high-intensity focused ultrasound (HIFU) therapy device is a non-invasive or minimally invasive therapeutic system that uses high-energy ultrasound waves to generate localized thermal or mechanical effects at a targeted focal point within the body. By concentrating acoustic energy into a small focal region, the system induces rapid temperature elevation (typically above 60–100°C) or cavitation effects, resulting in precise coagulative necrosis while minimizing damage to surrounding tissues.
How is the High-Intensity Focused Ultrasound (HIFU) Therapy Device market segmented by type?
By type, the market is segmented into Ultrasound-Guided Type and MRI-Guided Type.
What are the key applications of High-Intensity Focused Ultrasound (HIFU) Therapy Device?
Key applications covered include Oncology Treatment, Gynecological Treatment, Prostate Treatment, Aesthetic Body Contouring and Others.
Which companies are profiled in the High-Intensity Focused Ultrasound (HIFU) Therapy Device market report?
Key players profiled include InSightec, EDAP TMS, Profound Medical, Theraclion, Chongqing Haifu, Shanghai A&S, Alpinion and EpiSonica, among 15 companies covered in total.
What geographies does the High-Intensity Focused Ultrasound (HIFU) Therapy Device market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for High-Intensity Focused Ultrasound (HIFU) Therapy Device?
What factors are driving High-Intensity Focused Ultrasound (HIFU) Therapy Device market growth, globally and by region?
What are the main risks and barriers in the High-Intensity Focused Ultrasound (HIFU) Therapy Device market?
The overall industry gross margin generally ranges from 50% to 70%, reflecting high technological barriers and strong regulatory requirements in advanced therapeutic equipment markets.
Who should buy the High-Intensity Focused Ultrasound (HIFU) Therapy Device market report?
The report is intended for manufacturers and solution providers, distributors and end users in Oncology Treatment, Gynecological Treatment and Prostate Treatment, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the High-Intensity Focused Ultrasound (HIFU) Therapy Device market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.